CD300LF
From Wikipedia, the free encyclopedia
CD300 molecule-like family member f
|
|||||||||||
PDB rendering based on 2nms. | |||||||||||
Available structures: 2nms | |||||||||||
Identifiers | |||||||||||
Symbol(s) | CD300LF; NKIR; CD300f; CLM1; IREM1; IgSF13 | ||||||||||
External IDs | OMIM: 609807 MGI: 2442359 HomoloGene: 51396 | ||||||||||
|
|||||||||||
Orthologs | |||||||||||
Human | Mouse | ||||||||||
Entrez | 146722 | 246746 | |||||||||
Ensembl | ENSG00000186074 | ENSMUSG00000047798 | |||||||||
Uniprot | Q8TDQ1 | Q6SJQ7 | |||||||||
Refseq | NM_139018 (mRNA) NP_620587 (protein) |
NM_145634 (mRNA) NP_663609 (protein) |
|||||||||
Location | Chr 17: 70.2 - 70.22 Mb | Chr 11: 114.93 - 114.95 Mb | |||||||||
Pubmed search | [1] | [2] |
CD300 molecule-like family member f, also known as CD300LF, is a human gene.[1]
CD300LF is an inhibitory receptor of the Ig superfamily expressed on myeloid cells. It mediates negative regulatory signals by recruiting SHP1 (PTPN6; MIM 176883) or SHIP (INPP5D; MIM 601582) (Sui et al., 2004; Alvarez-Errico et al., 2004).[supplied by OMIM][1]
[edit] References
[edit] Further reading
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi: . PMID 12477932.
- Clark HF, Gurney AL, Abaya E, et al. (2003). "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.". Genome Res. 13 (10): 2265–70. doi: . PMID 12975309.
- Chung DH, Humphrey MB, Nakamura MC, et al. (2004). "CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation.". J. Immunol. 171 (12): 6541–8. PMID 14662855.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40–5. doi: . PMID 14702039.
- Sui L, Li N, Liu Q, et al. (2004). "IgSF13, a novel human inhibitory receptor of the immunoglobulin superfamily, is preferentially expressed in dendritic cells and monocytes.". Biochem. Biophys. Res. Commun. 319 (3): 920–8. doi: . PMID 15184070.
- Zhang Z, Henzel WJ (2005). "Signal peptide prediction based on analysis of experimentally verified cleavage sites.". Protein Sci. 13 (10): 2819–24. doi: . PMID 15340161.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi: . PMID 15489334.
- Alvarez-Errico D, Aguilar H, Kitzig F, et al. (2005). "IREM-1 is a novel inhibitory receptor expressed by myeloid cells.". Eur. J. Immunol. 34 (12): 3690–701. doi: . PMID 15549731.
- Alvarez-Errico D, Sayós J, López-Botet M (2007). "The IREM-1 (CD300f) inhibitory receptor associates with the p85alpha subunit of phosphoinositide 3-kinase.". J. Immunol. 178 (2): 808–16. PMID 17202342.